BF you are probably the most arrogant distasteful unliveable poster I’ve come across in these boards and that is saying something!
If instead of trying to muddy the waters with utter cobblers YOU actually read what I posted you would have noticed I was agreeing with the essence of, if no deal it gets suspended but pointing out the fact that it was unlikely and posted a section from the most recent rns.
But no .... you have to post cobblers again as usual.
As previously disclosed, following the recent placing to raise gross proceeds of £650,000 the Company has sufficient working capital until February 2021 and the Directors remain focused on completing a RTO prior to that time.
Jonathan Gold, President and Chief Business Officer of Motif Bio, said: "Following the recent fundraise we are pleased to be in a position where we have several options to evaluate. We are currently working with our advisers to identify the most appropriate RTO candidate for the Company and look forward to providing our shareholders with further updates as appropriate."
If no deal and if no extension then yes they are suspended from trading and given another six month to get any deal over the line. But if you kept up with the workings of the London stock exchange you would know that in the circumstances we find ourselves in due to covid they are giving 6 month extensions.
“ The Company is in negotiations with several RTO candidates in the healthcare sector. The Covid-19 pandemic has created new opportunities for companies in the healthcare sector and the RTO candidates under current consideration are exploring ways in which their therapeutic product candidates may help patients with Covid-19.”
That section of this rns is brilliant !!!!!
So delist is as good as off the table imo! Multiple options and it’s just about picking the best one out of those that want us! I reckon iclaprim IS part of the negotiations reading between the lines ( certain negative posters said covid would have no impact whatsoever pffffft )
Peel Hunt wouldn’t be involved if we wasn’t at a advanced stage!
This is the section of the 7th May rns that bothers me the most.
While the Company would be required to raise a minimum of £6 million in cash via an equity fundraising to become an investing company, the Directors believe that substantially more will need to be raised for the Company to support an ongoing investing policy.